ClinicalTrials.gg
RecruitingNCT06996275AT-HOMEUpdated Sep 10, 2026

Attachment and Post-Traumatic Stress Disorder in Military Personnel: Characterization of the French Military Population, Exploration of Biopsychosocial Factors, and Study of the Impact of Security Priming on Emotional Contagion Capacities

An observational study in Post-traumatic Stress Disorder (PTSD) and Emotional Contagion, sponsored by Direction Centrale du Service de Santé des Armées. Recruiting at 1 site in France. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-10.

Sponsored by Direction Centrale du Service de Santé des Armées · Observational

From the registry’s dates

  • Started May 2025; still recruiting 1 year 5 months later.
Study type
Observational
Model
Case-control
Time perspective
Cross-sectional
Enrollment
94
Ages
18 Years to 65 Years
Sex
All
01

Study summary

Post-traumatic stress disorder (PTSD) is a pathology that impairs the quality of life of sufferers. In military personnel, it can lead to military incapacity. This psychopathology is characterized by confrontation with one or more traumatic events in the individual's life history. Symptoms include cognitive and mood disorders, avoidance, hyperactivation (hypervigilance and anger) and intrusions (flashbacks and nightmares).

Studies show that the prevalence of PTSD in military personnel fluctuates considerably from one situation to another (pre-deployment/post-deployment, etc.). In these at-risk populations, the often more complex PTSD clinic may also account for the heterogeneity of prevalences observed. Nevertheless, PTSD tends to become chronic in military personnel, making it particularly difficult to return to a "previous" state. In French casualties, beyond the symptoms already mentioned, complaints focus on difficulties in social interaction situations involving others in social life (attachment style to others) and in everyday life (public transport, supermarket shopping, social interactions, presence of crowds...).

In the context of post-traumatic stress disorder, the investigators would like to explore the processes of social cognition that enable people to interact in their environment, in relation to biological, psychosocial and physiological variables that may constitute risk or maintenance factors for the pathology.

02

Conditions studied

  • Post-traumatic Stress Disorder (PTSD)
  • Emotional Contagion

Keywords

  • PTSD
  • complex PTSD
  • military veteran
  • emotional contagion
  • oxytocin
  • vasopressine
03

In context

Stress Disorders, Post-Traumatic

2,682 studies on the registry are indexed under Stress Disorders, Post-Traumatic; 601 are open to participants now.

This study's planned enrollment of 94 is below the median of 150 across 371 observational studies indexed under Stress Disorders, Post-Traumatic.

Browse Stress Disorders, Post-Traumatic studies →

Lead sponsor

Direction Centrale du Service de Santé des Armées is the lead sponsor of 95 studies on the registry; 33 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

No-PTSD Group: Military personnel without PTSD will be recruited from within an infantry regiment of the army.

PTSD Group: Military personnel with PTSD will be recruited during workshops conducted by the CABAT (Cellule d'Aide aux Blessés de l'Armée de Terre - Army Wounded Support Unit) in 2025 and 2026.

Eligibility criteria

Inclusion Criteria:

Inclusion Criteria Common to Both Groups:

  • Volunteers who agreed to participate in the study and provided written consent
  • Affiliated with social security
  • Proficient in the French language

Inclusion Criteria Specific to the "Military Personnel with PTSD" Group:

  • Military personnel diagnosed with post-traumatic stress disorder related to their duties
  • Participants in activities offered by the wounded service support units

Exclusion Criteria:

  • Adults subject to a protective measure
  • Refusal to participate in the study
  • Unrectified Legionnaires
05

Study design

Observational model
Case-control
Time perspective
Cross-sectional
Enrollment
94 participants (estimated)
Patient registry
No
Biospecimen retention
Samples with dna

Groups and cohorts

  • PTSD-group

    military personnel or veterans suffering from PTSD

  • no PTSD-group

    military on active duty without PTSD

06

What researchers measure

Primary outcomes

  1. To characterize attachment styles within a military population by comparing a group of military personnel without PTSD (No-PTSD Group) with a group of military personnel with PTSD (PTSD Group).

    Our primary outcome measure involves a comparison of the proportions of individuals exhibiting a secure attachment style versus an insecure attachment style (including the subtypes anxious-avoidant, anxious-ambivalent, and disorganized) between the two groups, as assessed during the single study visit.

    Time frame: Baseline (Day 1)

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Miquel A, Chan W, Rouquet C, Mison J, Jolly M, Coutan M, Ferhani O, Trousselard M, Duffaud AM. Attachment and post-traumatic stress disorder in french military personnel: characterization and exploration of biopsychosocial factors - the at-home study protocol. MethodsX. 2026 Apr 22;16:103924. doi: 10.1016/j.mex.2026.103924. eCollection 2026 Jun. PubMed 42100750 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started May 2025 (actual). Primary completion is estimated for May 2027, 23 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
May 21, 2025
First posted
May 30, 2025
StartActual
May 28, 2025
Primary completionEst.
May 26, 2027
CompletionEst.
May 26, 2027
Last update
Sep 10, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 10, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06996275
Lead sponsor
Direction Centrale du Service de Santé des Armées
Responsible party
Sponsor
First posted
May 30, 2025
Start date
May 28, 2025
Primary completion
May 26, 2027 (estimated)
Completion
May 26, 2027 (estimated)
Last update
Sep 10, 2026

Study contacts

Anaïs Duffaud, PhD
Contact
anais.duffaud@intradef.gouv.fr
0033 1 78 65 13 15
Anaïs Duffaud, PhD
study director · Institut de Recherche Biomédicale des Armées

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion